• Sanofi
  •  Overview
  • Last Modified:
  • July 14, 2025
  • Company type:
  • Public
  • Industry:
  • Healthcare
  • Verified:
  • No
  • No of Employees:
  • 50 001 - 100 000
  • Stock Code:
  • SAN
  • Download
  • Signed Health Status Declaration Form
  • Turnover $50m + ?:
  • Yes
  • Headquarters:
  • France
  • Public Interest Score:
  • 750+

 

  • Sanofi
  • General Information

Description

Sanofi is a French multinational pharmaceutical and healthcare company headquartered in Paris. It was established in 1973 and is involved in the research, development, manufacturing, and marketing of various pharmaceutical products, including both prescription and over-the-counter medications. Sanofi operates in several key therapeutic areas, such as cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. 

Here’s a more detailed look at Sanofi:
  • Global Presence:

    Sanofi has a global footprint, operating in over 70 countries with more than 83,000 employees. 

  • Vaccines:

    Sanofi is a leading global producer of vaccines through its subsidiary, Sanofi Pasteur. 

  • Research and Development:

    The company is heavily involved in research and development, focusing on areas like immunology, with a goal to redefine the field. 

  • AI Integration:

    Sanofi is actively integrating AI into its operations to improve decision-making, optimize processes, and enhance the quality and speed of drug delivery. 

  • Key Drugs:

    Sanofi produces a range of well-known medications, including Dupixent, which has become a flagship product due to its strong market performance and therapeutic applications. 

  • South Africa Focus:

    Sanofi has a long history of operations in South Africa, aiming to improve people’s lives through its healthcare solutions. 

  • Partnerships:
    Sanofi collaborates with other companies, such as GSK, on projects like the COVID-19 vaccine. 
Frédéric Oudéa:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Paul Hudson:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Christophe Babule:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Clotilde Delbos:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Humberto De Sousa:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Rachel Duan:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Carole Ferrand:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Lise Kingo:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jean-Paul Kress:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Patrick Kron:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Wolfgang Laux:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Barbara Lavernos:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Anne-Françoise Nesmes:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
John Sundy:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Emile Voest:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Antione Yver:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No

Subsribe/ Login to view details on company risk rating

Subscribe / Login

 

5 Benchmark > 4 Excellent > 3  Good > 2 Caution > 1 Risk

 

  • Company Information
  • Company System Number:
  • 15528
  • Founded Year: 
  • 1973
  • Registration Number: 
  • 775 662 257
  • Country: 
  • France
  • Stock Exchanges: 
    • Euronext Paris Exchange
  • Financial year end: 
  • December
  • No. of Countries operations: 
  • 70
  • Company Status: 
  • In Business
  • Industry Sub Category: 
  • Healthcare and Pharmaceutical
  • Date listed on Stock Exchange: 
  • 25/05/1999

 

  • Contact Information
  • Business operation: 
  • We are an innovative global healthcare company with one purpose: to chase the miracles of science to improve people's lives.
  • Primary office: 
  • 6 Ave De La Grande Armee 75017, Paris, Ile De France

 

  • Additional Information
  • Listed?: 
  • Yes
  • Company secretary: 
  • Chandu Parmar
  • Reporting currency: 
  • EUR
  • ISIN number (12 digit): 
EPA
FR0000120578
  • Authorised shares:
  • 2 467 152 142
  • Issued shares:
  • 1 253 591 640
  • No of shareholders:
  • 1001 and more shareholders
  • No of shareholders holding 20%:
  • 0 shareholders
  • Number of shares traded
  • Per Year:
  • Per Quarter:
  • Per Month:

 

Subscribe/ Login to view more details on Health Status 

Subscribe / Login

 

Shareholders holding 5% +


For a comprehensive list, please contact InsidEntity.

Material Subsidiaries/Associates


For a comprehensive list, please contact InsidEntity.

Credit Rating

NameLogoCountryHeadquartersRating
Moody'sCredit LogoUnited States of AmericaNew YorkA1

 

Countries Operations/ Offices


 

Company Directors

Name
Nationality
Age
Role
Qualification
Name

Frédéric

Non Executive
NationalityFrance
63
RoleChairman
QualificationENA(INSP)
Date Appointed: 01/05/2023
Duration:
3 years and 4 months
Independance: Y
Profile
Name

Paul

Executive
NationalityUnited Kingdom
58
RoleCEO
QualificationD.B.A, Degree Economics
Date Appointed: 01/05/2022
Duration:
4 years and 4 months
Independance: Y
Profile
Name

Christophe

Non Executive
NationalityFrance
60
RoleNED
QualificationM.B.A, HEC
Date Appointed: 01/02/2019
Duration:
7 years and 7 months
Independance: Y
Profile
Name

Clotilde

Non Executive
NationalityFrance
58
RoleNED
QualificationBAcc
Date Appointed: 01/04/2024
Duration:
2 years and 5 months
Independance: Y
Profile
Name

Humberto

Non Executive
NationalityFrance
48
RoleNED
QualificationSTI Baccalaureate (Baccalauréat STI) in Electrical Engineering
Date Appointed: 01/04/2025
Duration:
1 year and 5 months
Independance: Y
Profile
Name

Rachel

Non Executive
NationalityChina
56
RoleNED
QualificationBEcon and International Business, MBA
Date Appointed: 01/04/2020
Duration:
6 years and 5 months
Independance: Y
Profile
Name

Carole

Non Executive
NationalityFrance
56
RoleNED
QualificationHEC
Date Appointed: 01/05/2022
Duration:
4 years and 4 months
Independance: Y
Profile
Name

Lise

Non Executive
NationalityDenmark
64
RoleNED
QualificationBachelor degrees in Religions and Ancient Greek Art, Bachelor’s degree in Marketing and Economics
Date Appointed: 01/04/2020
Duration:
6 years and 5 months
Independance: Y
Profile
Name

Jean-Paul

Non Executive
NationalityAmerican
61
RoleNED
QualificationBSBC, MD, MSc
Date Appointed: 01/01/2025
Duration:
1 year and 8 months
Independance: Y
Profile
Name

Patrick

Non Executive
NationalityFrance
73
RoleNED
QualificationB.S
Date Appointed: 01/05/2022
Duration:
4 years and 4 months
Independance: Y
Profile
Name

Wolfgang

Non Executive
NationalityGermany
58
RoleNED
QualificationIFA, PhD
Date Appointed: 01/04/2021
Duration:
5 years and 5 months
Independance: Y
Profile
Name

Barbara

Non Executive
NationalityFrance
58
RoleNED
QualificationHEI
Date Appointed: 01/04/2021
Duration:
5 years and 5 months
Independance: Y
Profile
Name

Anne-Françoise

Non Executive
NationalityFrance
55
RoleNED
QualificationMaster’s degree from Grenoble Business School and a master’s degree in business administration
Date Appointed: 01/04/2024
Duration:
2 years and 5 months
Independance: Y
Profile
Name

John

Non Executive
NationalityAmerican
64
RoleNED
QualificationB.S. in biology, M.D./Ph.D
Date Appointed: 01/04/2024
Duration:
2 years and 5 months
Independance: Y
Profile
Name

Emile

Non Executive
NationalityNetherlands
67
RoleNED
QualificationPhD
Date Appointed: 01/05/2022
Duration:
4 years and 4 months
Independance: Y
Profile
Name

Antione

Non Executive
NationalityFrance
68
RoleNED
QualificationM.D
Date Appointed: 01/05/2022
Duration:
4 years and 4 months
Independance: Y
Profile

 

Directors Tenure

Name
Duration
Name

Frédéric Oudéa

Duration3 years and 4 months
Profile
Name

Paul Hudson

Duration4 years and 4 months
Profile
Name

Christophe Babule

Duration7 years and 7 months
Profile
Name

Clotilde Delbos

Duration2 years and 5 months
Profile
Name

Humberto De Sousa

Duration1 year and 5 months
Profile
Name

Rachel Duan

Duration6 years and 5 months
Profile
Name

Carole Ferrand

Duration4 years and 4 months
Profile
Name

Lise Kingo

Duration6 years and 5 months
Profile
Name

Jean-Paul Kress

Duration1 year and 8 months
Profile
Name

Patrick Kron

Duration4 years and 4 months
Profile
Name

Wolfgang Laux

Duration5 years and 5 months
Profile
Name

Barbara Lavernos

Duration5 years and 5 months
Profile
Name

Anne-Françoise Nesmes

Duration2 years and 5 months
Profile
Name

John Sundy

Duration2 years and 5 months
Profile
Name

Emile Voest

Duration4 years and 4 months
Profile
Name

Antione Yver

Duration4 years and 4 months
Profile

 

Director Experience

Name
Experience
Name

Frédéric

Experience Banking, Financial Services
Profile
Name

Paul

Experience Healthcare, Pharmaceutical
Profile
Name

Christophe

Experience Financial Services, Retail
Profile
Name

Clotilde

Experience Financial Services
Profile
Name

Rachel

Experience Electronics
Profile
Name

Carole

Experience Financial Services
Profile
Name

Lise

Experience Business Services
Profile
Name

Jean-Paul

Experience Pharmaceutical
Profile
Name

Patrick

Experience Financial Services
Profile
Name

Wolfgang

Experience Healthcare
Profile
Name

Barbara

Experience Retail, Chemicals
Profile
Name

Anne-Françoise

Experience Healthcare
Profile
Name

John

Experience Medical Equipment
Profile
Name

Emile

Experience Medical Equipment
Profile
Name

Antione

Experience Pharmaceutical
Profile
Name

Humberto

Experience Healthcare, Pharmaceutical, Engineering
Profile

 

Company Auditors

Name
Date Appointed
Years
Name

Ernst & Young

Date Appointed01/01/1999
Year27 years and 8 months
Profile

 

Company Past Directors

Name
ED/NED
Role
Name

Gilles

ED/NEDNon Executive
RoleNED
Date Appointed: 01/05/2022
Date Resigned: 01/01/2025
Profile
Name

Ceng-Yann

ED/NEDNon Executive
RoleDirector
Date Appointed: 01/05/2021
Date Resigned: 01/01/2025
Profile
Name

Fabienne

ED/NEDNon Executive
RoleNED
Date Appointed: 01/05/2023
Date Resigned: 01/01/2025
Profile

 

Company Committees

Name

Frédéric Oudéa

Mainboard, Audit, Remuneration BD, NG, OT
Profile
Name

Paul Hudson

Mainboard, Audit, Remuneration BD, EX, OT
Profile
Name

Christophe Babule

Mainboard, Audit, Remuneration BD, AU
Profile
Name

Clotilde Delbos

Mainboard, Audit, Remuneration BD, AU, RE
Profile
Name

Rachel Duan

Mainboard, Audit, Remuneration BD, AU, RE
Profile
Name

Carole Ferrand

Mainboard, Audit, Remuneration BD, AU
Profile
Name

Lise Kingo

Mainboard, Audit, Remuneration BD, NG, OT
Profile
Name

Jean-Paul Kress

Mainboard, Audit, Remuneration BD, OT
Profile
Name

Patrick Kron

Mainboard, Audit, Remuneration BD, RE, NG, OT
Profile
Name

Wolfgang Laux

Mainboard, Audit, Remuneration BD, RE
Profile
Name

Barbara Lavernos

Mainboard, Audit, Remuneration BD, NG, OT
Profile
Name

Anne-Françoise Nesmes

Mainboard, Audit, Remuneration BD, AU
Profile
Name

John Sundy

Mainboard, Audit, Remuneration BD, OT
Profile
Name

Emile Voest

Mainboard, Audit, Remuneration BD, OT
Profile
Name

Antione Yver

Mainboard, Audit, Remuneration BD, OT
Profile
Name

Humberto De Sousa

Mainboard, Audit, Remuneration BD
Profile

 

Committee
Abbreviation
Supervisory Board
SB
Board
BD
Risk & Compliance
RC
Audit
AU
Remuneration
RE
Capital investment
CI
Industry Specific
IS
Nominations & Governance
NG
Health, Safety & Environment
HS
Social & Ethics
SE
Technology
TE
Executive
EX
Other
OT